Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 184

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Clinical practice guidelines for BRCA1 and BRCA2 genetic testing

Open access
Pujol, Pascal, Barberis, Massimo, Beer, Philp, Friedman, Eitan, Piulats, Josep M., Capoluongo, Ettore D., Garcia Foncillas, Jesus, Ray-Coquard, Isabelle, Penault-Llorca, Frédérique, Foulkes, William D., Turnbull, Clare, Hanson, Helen, Narod, Steven, Arun, Banu K., Aapro, Matti S., Mandel, Jean-Louis, Normanno, Nicola, Lambrechts, Diether, Vergote, Ignace, Anahory, Michèle, Baertschi, Bernard, Baudry, Karen, Bignon, Yves-Jean, Bollet, Marc, Corsini, Carole, Cussenot, Olivier, De la Motte Rouge, Thibault, Duboys de Labarre, Marie, Duchamp, Florence, Duriez, Clarisse, Fizazi, Karim, Galibert, Virginie, Gladieff, Laurence, Gligorov, Joseph, Hammel, Pascal, Imbert-Bouteille, Marion, Jacot, William, Kogut-Kubiak, Tatiana, Lamy, Pierre-Jean, Nambot, Sophie, Neuzillet, Yann, Olschwang, Sylviane, Rebillard, Xavier, Rey, Jean-Marc, Rideau, Chloé, Spano, Jean-Philippe, Thomas, Frédéric, Treilleux, Isabelle, Vandromme, Marion, Vendrell, Julie, Vintraud, Michèle, Zarca, Daniel, Hughes, Kevin S., Alés Martínez, Jose E. · 2021 · European Journal of Cancer

Abstract

BRCA1 and BRCA2 gene pathogenic variants account for most hereditary breast cancer and are increasingly used to determine eligibility for PARP inhibitor (PARPi) therapy of BRCA-related cancer. Because issues of BRCA testing in clinical practice now overlap with both preventive and therapeutic management, updated and comprehensive practice guidelines for BRCA genotyping are needed. The integrative recommendations for BRCA testing presented here aim to (1) identify individuals who may benefit from genetic counselling and risk-reducing strategies; (2) update germline and tumour-testing indications for PARPi-approved therapies; (3) provide testing recommendations for personalised management of early and metastatic breast cancer; and (4) address the issues of rapid process and tumour analysis. An international group of experts, including geneticists, medical and surgical oncologists, pathologists, ethicists and patient representatives, was commissioned by the French Society of Predictive and Personalised Medicine (SFMPP). The group followed a methodology based on specific formal guidelines development, including (1) evaluating the likelihood of BRCAm from a combined systematic review of the literature, risk assessment models and expert quotations, and (2) therapeutic values of BRCAm status for PARPi therapy in BRCA-related cancer and for management of early and advanced breast cancer. These international guidelines may help clinicians comprehensively update and standardise BRCA testing practices.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2020.12.023

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 184

Metadata

Authors
Pujol, P., Barberis, M., Beer, P., Friedman, E., Piulats, J. M., Capoluongo, E. D., Garcia Foncillas, J., Ray-Coquard, I., Penault-Llorca, F., Foulkes, W. D., Turnbull, C., Hanson, H., Narod, S., Arun, B. K., Aapro, M. S., Mandel, J.-L., Normanno, N., Lambrechts, D., Vergote, I., Anahory, M., Baertschi, B., Baudry, K., Bignon, Y.-J., Bollet, M., Corsini, C., Cussenot, O., De la Motte Rouge, T., Duboys de Labarre, M., Duchamp, F., Duriez, C., Fizazi, K., Galibert, V., Gladieff, L., Gligorov, J., Hammel, P., Imbert-Bouteille, M., Jacot, W., Kogut-Kubiak, T., Lamy, P.-J., Nambot, S., Neuzillet, Y., Olschwang, S., Rebillard, X., Rey, J.-M., Rideau, C., Spano, J.-P., Thomas, F., Treilleux, I., Vandromme, M., Vendrell, J., Vintraud, M., Zarca, D., Hughes, K. S., & Alés Martínez, J. E.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2021-03
Volume
146
Pages
30-47
ISSN
0959-8049 (ISSN-L)
OpenAlex
W3128456160
Cited by
184
References
7
FWCI
17.37
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. https://app.cochat.ai/papers/10.1016/j.ejca.2020.12.023
The paper
Pujol, P., Barberis, M., Beer, P., Friedman, E., Piulats, J. M., Capoluongo, E. D., Garcia Foncillas, J., Ray-Coquard, I., Penault-Llorca, F., Foulkes, W. D., Turnbull, C., Hanson, H., Narod, S., Arun, B. K., Aapro, M. S., Mandel, J.-L., Normanno, N., Lambrechts, D., Vergote, I., . . . Alés Martínez, J. E. (2021). Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2020.12.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.